Valbiotis SA (EPA:ALVAL)
France · Delayed Price · Currency is EUR 0.7780
+0.0080 (1.04%)
Aug 3, 2026, 1:19 PM CET
Valbiotis Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1.05 | 4.64 | 6.81 | 2.81 | 2.69 | |
Revenue Growth | -77.48% | -31.80% | 141.97% | 4.49% | -47.19% |
Cost of Revenue | 2.07 | 2.34 | 2.04 | - | - |
Gross Profit | -1.03 | 2.3 | 4.77 | 2.81 | 2.69 |
Selling, General & Admin | 7.24 | 7.46 | 4.18 | 3.35 | 2.62 |
Research & Development | 0.92 | 4.64 | 7.15 | 9.1 | 7.03 |
Other Operating Expenses | 0.31 | 0.63 | 0.62 | 2.38 | 1.52 |
Total Operating Expenses | 8.47 | 12.73 | 11.95 | 14.84 | 11.17 |
Operating Income | -9.49 | -10.42 | -7.18 | -12.03 | -8.48 |
Interest Income | 0.03 | 0.66 | - | 0 | 0.14 |
Interest Expense | - | - | -0.19 | -0.23 | -0.23 |
Other Non-Operating Income (Expense) | 0.05 | -0.23 | - | -0.06 | -0.12 |
Total Non-Operating Income (Expense) | 0.08 | 0.43 | -0.19 | -0.29 | -0.21 |
Pretax Income | -9.42 | -9.99 | -7.37 | -12.31 | -8.68 |
Provision for Income Taxes | -0 | -0.03 | - | 0 | - |
Net Income | -9.41 | -9.96 | -7.37 | -12.32 | -8.68 |
Net Income to Common | -9.42 | -10.03 | -7.37 | -12.31 | -8.68 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 20 | 16 | 12 | 10 | 9 |
Shares Outstanding (Diluted) | 20 | 16 | 12 | 10 | 9 |
Shares Change | 25.53% | 26.74% | 23.21% | 10.45% | 22.88% |
EPS (Basic) | -0.47 | -0.63 | -0.59 | -1.21 | -0.94 |
EPS (Diluted) | -0.47 | -0.63 | -0.59 | -1.21 | -0.94 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -8.05 | -11.68 | -8.08 | -9.3 | -7.46 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Per Share | -0.41 | -0.74 | -0.65 | -0.92 | -0.81 |
Gross Margin | -97.99% | 49.61% | 69.98% | 100.00% | 100.00% |
Operating Margin | -907.65% | -224.46% | -105.45% | -427.36% | -314.74% |
Profit Margin | -900.00% | -214.43% | -108.21% | -437.67% | -322.39% |
FCF Margin | -769.22% | -251.59% | -118.71% | -330.60% | -277.09% |
EBITDA | -9.2 | -9.84 | -6.44 | -11.17 | -7.54 |
EBITDA Margin | -879.35% | -211.82% | -94.64% | -397.09% | -279.80% |
EBIT | -9.49 | -10.42 | -7.18 | -12.03 | -8.48 |
EBIT Margin | -907.65% | -224.46% | -105.45% | -427.36% | -314.74% |
Effective Tax Rate | 0.02% | 0.34% | 0.00% | -0.02% | 0.00% |